Search by Drug Name or NDC
NDC 45802-0680-28 levocetirizine dihydrochloride 0.5 mg/mL Details
levocetirizine dihydrochloride 0.5 mg/mL
levocetirizine dihydrochloride is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is LEVOCETIRIZINE DIHYDROCHLORIDE.
MedlinePlus Drug Summary
Levocetirizine is used to relieve runny nose; sneezing; and redness, itching, and tearing of the eyes caused by hay fever, seasonal allergies, and allergies to other substances such as dust mites, animal dander, and mold. It is also used to treat symptoms of hives, including itching and rash. Levocetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 45802-0680-28Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Levocetirizine
Product Information
| NDC | 45802-0680 |
|---|---|
| Product ID | 45802-680_6b5f49f0-c974-47f1-a5c9-59b68623c122 |
| Associated GPIs | 41550027102020 |
| GCN Sequence Number | 062168 |
| GCN Sequence Number Description | levocetirizine dihydrochloride SOLUTION 2.5 MG/5ML ORAL |
| HIC3 | Z2Q |
| HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
| GCN | 97950 |
| HICL Sequence Number | 022959 |
| HICL Sequence Number Description | LEVOCETIRIZINE DIHYDROCHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | levocetirizine dihydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Levocetirizine dihydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091263 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0680-28 (45802068028)
| NDC Package Code | 45802-680-28 |
|---|---|
| Billing NDC | 45802068028 |
| Package | 148 mL in 1 BOTTLE (45802-680-28) |
| Marketing Start Date | 2011-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.17573 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | LEVOCETIRIZINE 2.5 MG/5 ML SOL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis